Virucidal efficacy of guanidine-free inactivants and rapid test buffers against SARS-CoV-2

A pathogen inactivation step during collection or processing of clinical samples has the potential to reduce infectious risks associated with diagnostic procedures. It is essential that these inactivation methods are demonstrated to be effective, particularly for non-traditional inactivation reagent...

Descripción completa

Detalles Bibliográficos
Autores principales: Davies, Katherine, Arnold, Ulrike, Buczkowski, Hubert, Burton, Christopher, Welch, Stephen R., Green, Nicole, Strachan, Rhea, Beetar-King, Tracy, Spencer, Peter, Hettiarachchi, Nipunadi, Hannah, Matthew J., Jones, Matthew, Cane, Patricia A., Bruce, Christine B., Woodford, Neil, Roberts, Allen D. G., Killip, Marian J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8642387/
https://www.ncbi.nlm.nih.gov/pubmed/34862448
http://dx.doi.org/10.1038/s41598-021-02942-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8642387/
https://www.ncbi.nlm.nih.gov/pubmed/34862448
http://dx.doi.org/10.1038/s41598-021-02942-4

Ejemplares similares